Best Life Sciences Companies in Skane County, Sweden

Developer of therapeutics to treat rare immunological diseases. The company is developing and commercializing immunomodulating therapies across transplantation, autoimmune diseases, gene therapy, and oncology indications.

Funding rounds

• Mar 2026Post IPO$30M
• Jul 2022Post IPO$70M
• Jul 2020Post IPO$121M
• Nov 2017Post IPO$65.5M

Founders & team

Soren TulstrupPresident & Ceo

Investors

NovaQuest Capital Management, Athyrium Capital Management, Nxt2b

Tech stack

Apple Icloud MailCloudflareCloudflare StreamHstsJsdelivrLottiefiles

MedVASC AB is providing a surgical tool for intraoperative drug delivery. They made a single cut through laser or catheter then puncture the vein wall through an anesthetic needle to numb the surrounding tissue. Through the fast treatment, surgery time is reduced by a half.

Funding rounds

• Jan 2026Series A$2.6M
• May 2025Seed$1M

Founders & team

Michael AkessonFounderCathrin JohanssonCEO

Investors

Smile Incubator

Provider of smart microscopy solution for biomedical research. It offers platform which is hardware agnostic and works with motorized microscope to analyse qualitatively each individual cell and high resolution contextual imaging to the population wide sample.The platform automates the entire microscopy process, from image acquisition to real time analysis, using AI and machine learning.

Funding rounds

• Oct 2025Series A$3.5M
• Feb 2024Seed—

Founders & team

Johannes AhnlideCo-Founder & CTOPhilip NordenfeltCo-Founder and CEO

Investors

Icebreaker, SmiLe Incubator, Ugly Duckling Ventures

Tech stack

CloudflareGoogle AnalyticsGoogle Tag ManagerGoogle WorkspaceHstsNext.Js

Developer of bone mineral platform for local cancer drug delivery. The platform facilitates controlled and sustained release of medication directly at the tumor site. This improves treatment outcomes and reduces side effects. The system uses biocompatible bone minerals to form a solid pellet implant. This implant delivers chemotherapy directly into tumor tissue. It increases local drug exposure while reducing harm to healthy tissue.

Funding rounds

• Oct 2025Seed$989.4K

Founders & team

Deepak RainaCo-Founder & CTOLudvig SjobergCEO

Developer of a novel drug for neuropathic pain relief solutions. It focuses on creating treatments without the side effects of conventional opioids. It is currently preparing for phase two studies with its lead candidate. It aims to provide effective neuropathic pain relief.

Funding rounds

• Jul 2024Series A$16.3M
• Jul 2024Grant (prize money)$2.7M
• Jun 2022Seed$2M
• Nov 2020Seed$2.5M

Founders & team

Bengt MentzerFounder & PresidentPer MentzerCEO

Investors

Karolinska Development, Europa, Sciety, Almi Invest

Provider of ventilation systems designed for infection control in healthcare. The company offers systems adaptable to environments requiring clean air and zones. It provides solutions aligned with energy efficiency and expertise. The company also delivers service solutions and digital monitoring systems.

Funding rounds

• May 2025Seed$308.8K
• Feb 2015Seed$2.6M

Founders & team

Peter HojerbackCEO

Investors

SEB, Almi Invest, Industrifonden, Argentum Group

Tech stack

Contact Form 7CookieyesCore-JsGoogle Font ApiGoogle Tag ManagerGsap

Developer of cancer immunotherapeutic solutions based on direct cell reprogramming. The company has developed TrojanDC cancer immunotherapy by using dendritic cell reprogramming that has anti-tumor immunity power to suppress T-cell responses to cancers. It uses gene therapy-based technology that allows cancer cells to be immunogenic & unleashes the immune system against cancer.

Funding rounds

• Mar 2024Series A$32.8M
• Jul 2023Grant (prize money)$81.9K
• Nov 2021Seed$6.9M
• May 2020Grant (prize money)$55.5K

Founders & team

Cristiana PiresCo-Founder & CEOFilipe PereiraCo-Founder

Investors

Novo Holdings, Johnson & Johnson Innovation, Boehringer Ingelheim Venture Fund, Industrifonden, RV Invest, Europa

Tech stack

Animate.CssBootstrapCdnjsCloudflareJqueryJquery Migrate

Developer of nanofiber-based cell culture products for upstream bioprocessing. The company's technology is scalable and customizable for research and development. It enables the development of improved cell culture products. The products are for cell and gene therapy and novel vaccines production. The company has implemented good manufacturing practice processes for production. It collaborates with contract development and manufacturing organizations and biopharmaceutical companies.

Funding rounds

• Sep 2024Seed$3.5M
• Oct 2023Seed$3.5M
• Jul 2023Seed—

Founders & team

Maximilian OttossonFounder & COOErik FredstorpFounderUwe GottschalkChairman of Board

Investors

Industrifonden, Europa, Onsight Ventures, EIC Fund, Smile Incubator

Tech stack

Apache Http ServerCookiebotCore-JsGoogle AnalyticsGoogle Font ApiGoogle Tag Manager

Developer of therapeutic antibodies against cancer. It offers recombinant antibody technology to enhance immunotherapy which includes LB01 novel target for checkpoint inhibition in leukemia and solid tumors, LB02 target selectively expressed on leukemic cells, and LB03 an innate immune checkpoint inhibitor.

Funding rounds

• Aug 2025Seed$259.2K

Founders & team

Thoas FioretosCo-FounderCarl SandenCo-FounderMarcus JarasCo-Founder

Investors

Almi Invest, I Love Lund

The company develops wearable device for stroke detection that consists of two bracelets with sensors and wireless communication with a smartphone. The Stroke Alarm provides an early indication of suspected stroke so that the victim can access care in time for treatment.

Funding rounds

• Aug 2024Seed$289.5K
• Oct 2020Seed$716.8K
• Jan 2020Seed$528.4K
• May 2019Grant (prize money)$55.8K

Founders & team

Johan WasseliusCo-FounderCecilia BelfrageCo-Founder & CEO

Investors

EIT Health, Swelife, Medtech4Health, I Love Lund, Karolina Ventures, Neuromathic

Manufacturer of medical needles

Funding rounds

• Jan 2025Seed$726.6K

Founders & team

Anna LindstromCo-FounderAnders GrimCo-Founder

Investors

SmiLe Incubator, Almi Invest, Carl Westin

Provider of nanowire-based sensors. It provides nanowire material types and dimensions to organize and align the nanowires on platforms. It also provides technology to enable nanowires to detect single molecules at an order of magnitude optical contrast. It also owns a patent regarding nanowire development.

Funding rounds

• Aug 2024Seed$389.7K
• 2023Grant (prize money)$54.6K
• Jun 2022Grant (prize money)$2.5M
• Oct 2019Seed$518.8K

Founders & team

Jaime Castillo-LeonCo-Founder & Director

Investors

Europa, SmiLe Incubator, EIC Fund, Mist Ventures, Lund University, Almi Invest

Tech stack

CloudflareCloudflare Bot ManagementCore-JsGoogle Font ApiGoogle Tag ManagerHsts